Ostarine, also referred to by its research code MK-2866, has become one of the most studied selective androgen receptor modulators in preclinical circles. For laboratory professionals and independent investigators across Australia, the compound’s tissue‑selective properties offer a fascinating avenue for in-vitro and animal model research. However, the growing demand has flooded the market with unverified…